透析前慢性肾脏病患者铁状态异常与死亡率增加相关
该历史队列研究利用退伍军人事务企业数据仓库数据,纳入2006-2015年间至少有一套铁指标的透析前CKD患者80,067例,按转铁蛋白饱和度和铁蛋白联合四分位分为四组,采用倾向评分匹配权重和Poisson回归比较全因死亡率。中位随访4.0年,三个异常铁组死亡率均高于参考组,其中功能性缺铁风险最高,糖尿病与非糖尿病亚组间无差异。
要点
- 透析前CKD患者中铁状态异常与全因死亡率增加相关
- 功能性缺铁(转铁蛋白饱和度0.8-16%,铁蛋白109-2783 ng/ml)死亡风险最高,调整相对率为1.21
- 糖尿病与非糖尿病亚组中各铁组的死亡风险相似
核心结论
- 透析前CKD患者中铁平衡异常,尤其是功能性缺铁,与全因死亡率增加相关。
研究设计与样本
- 历史队列研究,利用退伍军人事务企业数据仓库数据,纳入2006-2015年间至少有一套铁指标的透析前CKD患者80,067例,成功匹配32,489例。
主要发现
- 平均随访4.0年,与参考组(转铁蛋白饱和度16-28%,铁蛋白55-205 ng/ml)相比,功能性缺铁组全因死亡率调整相对率为1.21(95%CI 1.17, 1.25)。
- 低铁组(转铁蛋白饱和度0.4-16%,铁蛋白0.4-55 ng/ml)全因死亡率调整相对率为1.10(95%CI 1.07, 1.14)。
- 高铁组(转铁蛋白饱和度28-99.6%,铁蛋白205-4941 ng/ml)全因死亡率调整相对率为1.09(95%CI 1.06, 1.13)。
- 糖尿病与非糖尿病亚组中各铁组的死亡风险相似。
关键数值与推荐
- 铁状态分组依据转铁蛋白饱和度(%)和铁蛋白(ng/ml)的联合四分位:参考组16-28%且55-205 ng/ml;低铁组0.4-16%且0.4-55 ng/ml;高铁组28-99.6%且205-4941 ng/ml;功能性缺铁组0.8-16%且109-2783 ng/ml。
临床怎么用
- 在透析前CKD患者中应关注铁状态异常,尤其是功能性缺铁,其与死亡率增加相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Iron parameters have not been well characterized in pre-dialysis patients with chronic kidney disease (CKD), and it remains unclear if abnormal iron balance is associated with increased mortality. Therefore, we performed a historical cohort study using data from the Veterans Affairs Corporate Data Warehouse to evaluate the relationship between iron status and mortality. We identified a pre-dialysis CKD cohort with at least one set of iron indices between 2006-2015. The cohort was divided into four iron groups based on the joint quartiles of serum transferrin saturation (percent) and ferritin concentration (ng/ml): reference (16-28%, 55-205 ng/ml), low iron (0.4-16%, 0.4-55 ng/ml), high iron (28-99.6%, 205-4941 ng/ml), and function iron deficiency (0.8-16%, 109-2783 ng/ml). We compared mortality risk between the iron groups using matching weights based on multinomial propensity score models and Poisson rate-based regression. We also evaluated if the association between iron groups and mortality differs between the diabetic and non-diabetic subgroups. Of the 80,067 eligible veterans, 32,489 were successfully matched. During the mean follow-up period of 4.0 years, adjusted relative rate (95% confidence interval) for all-cause mortality in three abnormal iron groups were increased compared to the reference: functional iron deficiency [1.21 (1.17, 1.25)], low iron [1.10 (1.07, 1.14)], and high iron [1.09 (1.06, 1.13)]. The mortality risk was similar between diabetic and non-diabetic subgroups for each iron group. Thus, an abnormal iron balance, particularly functional iron deficiency, is associated with increased mortality in CKD.
引用
- Cho ME, Hansen JL, Peters CB, et al. An increased mortality risk is associated with abnormal iron status in diabetic and non-diabetic Veterans with predialysis chronic kidney disease. Kidney Int. 2019. PMID: 31345582. doi:10.1016/j.kint.2019.04.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。